COHERUS ONCOLOGY INC (CHRS) Stock Earnings & Estimates
USA - NASDAQ:CHRS - US19249H1032 - Common Stock
1.7 USD
+0.06 (+3.66%)
1.7 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 211M -35.39% | 257.244M 21.92% | 266.96M 3.78% | 47.187M -82.32% | 98.849M 109.48% | 98.247M -0.61% | 166.75M 69.73% | 231.18M 38.64% | 317.86M 37.49% | 499.5M 57.14% | 636.58M 27.44% | |
| EBITDA YoY % growth | -253.2M 2.76% | -194.508M 23.18% | -92.891M 52.24% | -179.52M -93.26% | -102.439M 42.94% | -55.549M 45.77% | -78.54M -41.39% | -55.08M 29.87% | -25.5M 53.70% | -14.28M 44.00% | -4.08M 71.43% | |
| EBIT YoY % growth | -256.9M 2.65% | -198.299M 22.81% | -98.167M 50.50% | -162.615M -65.65% | -115.523M 28.96% | -111.73M 3.28% | -120.097M -7.49% | -80.347M 33.10% | 12.183M 115.16% | 137.65M 1,029.85% | 235.44M 71.04% | |
| Operating Margin | -121.75% | -77.09% | -36.77% | -344.62% | -116.87% | -113.72% | -72.02% | -34.76% | 3.83% | 27.56% | 36.99% | |
| EPS YoY % growth | -3.03 -163.48% | -2.02 33.33% | -0.75 62.87% | -1.25 -66.60% | -0.74 40.41% | -0.69 7.31% | -0.97 -41.13% | -0.77 21.47% | -0.10 87.33% | 0.60 721.05% | 1.18 96.61% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.30 -2,858.00% | -0.21 23.50% | -0.24 31.03% | -0.14 59.00% | -0.24 17.24% | -0.09 57.14% |
| Revenue Q2Q % growth | 13.681M -80.67% | 16.081M -70.30% | 17.99M 136.74% | 32.235M 214.37% | 24.99M 82.66% | 48.96M 204.46% |
| EBITDA Q2Q % growth | -43.86M -1,945.71% | -43.86M -44.90% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -36.845M -476.87% | -33.238M 6.49% | -24.535M 46.00% | -28.964M 36.32% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.34 -142.86% | -0.33 | -0.01 | -4.17% |
| Q1 2025 Q2Q % growth | -0.35 -9.37% | -0.22 | -0.13 | -59.60% |
| Q4 2024 Q2Q % growth | -0.28 54.84% | -0.13 | -0.15 | -108.91% |
| Q3 2024 Q2Q % growth | -0.01 96.30% | -0.14 | 0.13 | 92.65% |
| Q2 2024 Q2Q % growth | -0.14 63.16% | -0.30 | 0.16 | 52.67% |
| Q1 2024 Q2Q % growth | -0.32 57.33% | -0.25 | -0.07 | -29.75% |
| Q4 2023 Q2Q % growth | -0.62 -3.33% | -0.12 | -0.50 | -410.06% |
| Q3 2023 Q2Q % growth | -0.27 71.88% | -0.28 | 0.01 | 3.63% |
| Q2 2023 Q2Q % growth | -0.38 19.15% | -0.49 | 0.11 | 23.14% |
| Q1 2023 Q2Q % growth | -0.75 25.00% | -0.58 | -0.17 | -28.45% |
| Q4 2022 Q2Q % growth | -0.60 -30.43% | -0.85 | 0.25 | 29.82% |
| Q3 2022 Q2Q % growth | -0.96 -182.35% | -0.58 | -0.38 | -65.12% |
| Q2 2022 Q2Q % growth | -0.47 -30.56% | -0.65 | 0.18 | 28.05% |
| Q1 2022 Q2Q % growth | -1.00 -10,100.00% | -0.49 | -0.51 | -103.19% |
| Q4 2021 Q2Q % growth | -0.46 -483.33% | -0.52 | 0.06 | 11.92% |
| Q3 2021 Q2Q % growth | -0.34 -203.03% | -0.22 | -0.12 | -51.52% |
| Q2 2021 Q2Q % growth | -0.36 -151.43% | -0.15 | -0.21 | -135.29% |
| Q1 2021 Q2Q % growth | 0.01 -98.15% | 0.07 | -0.06 | -85.70% |
| Q4 2020 Q2Q % growth | 0.12 -78.57% | 0.23 | -0.11 | -47.83% |
| Q3 2020 Q2Q % growth | 0.33 -47.62% | 0.41 | -0.08 | -20.21% |
| Q2 2020 Q2Q % growth | 0.70 118.75% | 0.34 | 0.36 | 105.06% |
| Q1 2020 Q2Q % growth | 0.54 286.21% | 0.57 | -0.03 | -4.85% |
| Q4 2019 Q2Q % growth | 0.56 | 0.74 | -0.18 | -24.23% |
| Q3 2019 Q2Q % growth | 0.63 | 0.52 | 0.11 | 21.58% |
| Q2 2019 Q2Q % growth | 0.32 | 0.00 | 0.32 | 10,091.26% |
| Q1 2019 Q2Q % growth | -0.29 | -0.48 | 0.19 | 39.18% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 10.254M -84.22% | 10.338M | -84K | -0.81% |
| Q1 2025 Q2Q % growth | 7.599M -90.14% | 55.753M | -48.154M | -86.37% |
| Q4 2024 Q2Q % growth | 54.144M -40.84% | 48.215M | 5.929M | 12.30% |
| Q3 2024 Q2Q % growth | 70.774M -5.09% | 60.415M | 10.359M | 17.15% |
| Q2 2024 Q2Q % growth | 64.979M 10.67% | 62.593M | 2.386M | 3.81% |
| Q1 2024 Q2Q % growth | 77.063M 137.58% | 81.853M | -4.79M | -5.85% |
| Q4 2023 Q2Q % growth | 91.524M 101.59% | 98.328M | -6.804M | -6.92% |
| Q3 2023 Q2Q % growth | 74.568M 64.25% | 84.363M | -9.795M | -11.61% |
| Q2 2023 Q2Q % growth | 58.716M -2.47% | 54.995M | 3.721M | 6.77% |
| Q1 2023 Q2Q % growth | 32.436M -46.03% | 48.386M | -15.95M | -32.96% |
| Q4 2022 Q2Q % growth | 45.4M -38.15% | 52.248M | -6.848M | -13.11% |
| Q3 2022 Q2Q % growth | 45.4M -44.97% | 58.048M | -12.648M | -21.79% |
| Q2 2022 Q2Q % growth | 60.2M -31.28% | 63.123M | -2.923M | -4.63% |
| Q1 2022 Q2Q % growth | 60.1M -27.59% | 70.331M | -10.231M | -14.55% |
| Q4 2021 Q2Q % growth | 73.4M -33.51% | 87.526M | -14.126M | -16.14% |
| Q3 2021 Q2Q % growth | 82.5M -27.38% | 93.135M | -10.635M | -11.42% |
| Q2 2021 Q2Q % growth | 87.6M -35.45% | 89.943M | -2.343M | -2.60% |
| Q1 2021 Q2Q % growth | 83M -28.57% | 97.923M | -14.923M | -15.24% |
| Q4 2020 Q2Q % growth | 110.4M -10.90% | 117.43M | -7.03M | -5.99% |
| Q3 2020 Q2Q % growth | 113.6M 1.70% | 125.34M | -11.74M | -9.37% |
| Q2 2020 Q2Q % growth | 135.7M 62.71% | 107.05M | 28.65M | 26.76% |
| Q1 2020 Q2Q % growth | 116.2M 213.21% | 121.91M | -5.71M | -4.68% |
| Q4 2019 Q2Q % growth | 123.9M | 125.47M | -1.57M | -1.25% |
| Q3 2019 Q2Q % growth | 111.7M | 103.63M | 8.07M | 7.79% |
| Q2 2019 Q2Q % growth | 83.4M | 68.696M | 14.704M | 21.40% |
| Q1 2019 Q2Q % growth | 37.1M | 37.702M | -602K | -1.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -14.48% | 0% | -6.83% |
| Revenue | 0.68% | -4.39% | -0.43% | -17.49% |